Tegaserod is effective in the retreatment of irritable bowel syndrome with constipation (IBS-C)

被引：5

|

作者：

Mueller-Lissner, S

Holtmann, G

Loeffler, H

Rueegg, P

机构：

来源：

GASTROENTEROLOGY | 2003年 / 124卷 / 04期

关键词：

D O I：

10.1016/S0016-5085(03)82905-0

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：A574 / A574

页数：1

相关论文

共 50 条

[41] Factors Contributing to Treatment Satisfaction in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) Treated With Linaclotide vs Placebo
Lembo, Anthony
Carson, Robyn
Shiff, Steven J.
Lavins, Bernard J.
MacDougall, James E.
Shi, Kelvin
Schneier, Harvey
Currie, Mark G.
Johnston, Jeffrey M.
GASTROENTEROLOGY, 2012, 142 (05) : S822 - S823
[42] Plecanatide Is Efficacious in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) and Bloating: Evaluation Using Trisymptom Composite Endpoints
Brenner, Darren M.
Shin, Andrea S.
Laitman, Adam P.
Kunkel, David C.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S551 - S551
[43] ROLE OF DIETARY HABITS ON SYMPTOM CONTROL AND GUT MICROBIOTA COMPOSITION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C)
Altomare, A.
Di Rosa, C.
Putignani, L.
Emerenziani, S.
Fabris, S.
Ristori, M., V
Crucilla, S.
Calo, C.
Nicolo, R.
Ciccozzi, M.
Cicala, M.
Guarino, M. P. L.
DIGESTIVE AND LIVER DISEASE, 2022, 54 : S131 - S132
[44] EFFECT OF TENAPANOR ON TREATMENT SATISFACTION, DEGREE OF RELIEF, AND QUALITY OF LIFE FOR PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C)
Chey, William D.
Edelstein, Susan
Yang, Yang
Rosenbaum, David P.
GASTROENTEROLOGY, 2022, 162 (07) : S756 - S756
[45] Disease Burden and Care-Seeking Behavior of Patients With Irritable Bowel Syndrome With Constipation (IBS-C) in the United States
Lacy, Brian E.
Taylor, Douglas C.
Xu, Yanqing
Kosch, Katherine J.
Dobrescu, Rachel
Morlock, Amy
Morlock, Robert
Rooker, Ceciel
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S402 - S402
[46] Tegaserod: A promising option in women with irritable bowel syndrome with constipation
不详
Drugs & Therapy Perspectives, 2004, 20 (6) : 1 - 4
[47] Efficacy and Tolerability of Linaclotide and Plecanatide in Treating Irritable Bowel Syndrome With Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC): A Meta-Analysis
Shah, Eric D.
Pimentel, Mark
Kim, Hyungjin
Schoenfeld, Philip
GASTROENTEROLOGY, 2016, 150 (04) : S739 - S739
[48] Efficacy and tolerability of linaclotide and plecanatide in treating Irritable Bowel Syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC): A meta-analysis
Shah, E.
Pimentel, M.
Kim, H.
Schoenfeld, P.
NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 : 101 - 101
[49] ROME III Functional Constipation (FC) and Irritable Bowel Syndrome - Constipation Predominant (IBS-C) - Truly Distinct Disorders or One Disease Spectrum?
Koloski, Natasha A.
Jones, Michael P.
Young, Melissa
Talley, Nicholas J.
GASTROENTEROLOGY, 2013, 144 (05) : S917 - S918
[50] PINNACLE: Practical Approaches Towards Improving Patient Outcomes for Chronic Constipation and Irritable Bowel Syndrome with Constipation (IBS-C) among Older Adults
Byrd, Lisa
GERIATRIC NURSING, 2010, 31 (02) : 143 - 146

← 1 2 3 4 5 →